David L. Willins - Concepedia

Author

David L. Willins

Case Western Reserve University

Also Known As

D L Willins, D. L. WILLINS, D.L. Willins, David L Willins, David L. Willins, David Willins

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Case Western Reserve University Vanderbilt University University School The Ohio State University

About

David L. Willins is an author at Case Western Reserve University specializing in neuropharmacology, medicine, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	420
2	Social Sciences	4	4	249
3	Neuroscience	4	4	249
4	Pharmacology	4	4	331
5	Psychiatry	1	1	27

David L. Willins

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex David L. Willins, Ariel Y. Deutch, Bryan L. Roth Synapse	1997	343
Direct Injection of 5-HT2A Receptor Agonists into the Medial Prefrontal Cortex Produces a Head-Twitch Response in Rats David L. Willins, Herbert Y. Meltzer Journal of Pharmacology and Experimental Therapeutics	1997	239
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo David L. Willins, Susan A. Berry, L. Alsayegh, Neuroscience Molecular PharmacologyFunctional Selectivity5-Hydroxytryptamine-2a ReceptorsMedicinePhysiology	1999	171
The Dynamin-dependent, Arrestin-independent Internalization of 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptors Reveals Differential Sorting of Arrestins and 5-HT2A Receptors during Endocytosis Anushree Bhatnagar, David L. Willins, J.A. Gray, Journal of Biological Chemistry	2001	162
A Highly Conserved Aspartic Acid (Asp-155) Anchors the Terminal Amine Moiety of Tryptamines and Is Involved in Membrane Targeting of the 5-HT2A Serotonin Receptor But Does Not Participate in Activation via a “Salt-Bridge Disruption” Mechanism Kurt Kristiansen, Wesley K. Kroeze, David L. Willins, Journal of Pharmacology and Experimental Therapeutics	2000	115
The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801 David L. Willins, Shridhar Narayanan, Lane J. Wallace, Pharmacology Biochemistry and Behavior Hypermotility ResponseSynaptic SignalingBehavioral NeuroscienceAmpa/kainate ReceptorsPhysiology	1993	89
Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens David L. Willins, Herbert Y. Meltzer Brain Research Serotonin 5-Ht2c AgonistsBehavioral NeuroscienceNeurophysiologyAddictionMedicine	1998	76
The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA Robert C. Boldry, David L. Willins, Lane J. Wallace, Brain Research Intra-accumbens AmpaHypermotility ResponseBehavioral NeuroscienceNeurophysiologyMedicine	1991	57
Serotonergic Antagonist Effects on Trafficking of Serotonin 5‐HT<sub>2A</sub> Receptors <i>in Vitro</i> and <i>in Vivo</i><sup>a</sup> David L. Willins, L. Alsayegh, Susan A. Berry, Annals of the New York Academy of Sciences	1998	53
alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs. David L. Willins, Lane J. Wallace, David D. Miller, Journal of Pharmacology and Experimental Therapeutics	1992	46

Page 1